1
|
Lu Y, Zhao X, Liu Q, Li C, Graves-Deal R,
Cao Z, Singh B, Franklin JL, Wang J, Hu H, et al: lncRNA
MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance
via Wnt/β-catenin signaling. Nat Med. 23:1331–1341. 2017.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan
C, Xu M, Sun H, Liu C, Wei P and Du X: The lncRNA NEAT1 activates
Wnt/β-catenin signaling and promotes colorectal cancer progression
via interacting with DDX5. J Hematol Oncol. 11:1132018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Giraldez MD, Spengler RM, Etheridge A,
Godoy PM, Barczak AJ, Srinivasan S, De Hoff PL, Tanriverdi K,
Courtright A, Lu S, et al: Comprehensive multi-center assessment of
small RNA-seq methods for quantitative miRNA profiling. Nat
Biotechnol. 36:746–757. 2018. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhang Y, Su X, Kong Z, Fu F, Zhang P, Wang
D, Wu H, Wan X and Li Y: An androgen reduced transcript of lncRNA
GAS5 promoted prostate cancer proliferation. PLoS One.
12:e01823052017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Luo L, Tang H, Ling L, Li N, Jia X, Zhang
Z, Wang X, Shi L, Yin J, Qiu N, et al: LINC01638 lncRNA activates
MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation
in triple-negative breast cancer. Oncogene. 37:6166–6167. 2018.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Yuan JH, Liu XN, Wang TT, Pan W, Tao QF,
Zhou WP, Wang F and Sun SH: The MBNL3 splicing factor promotes
hepatocellular carcinoma by increasing PXN expression through the
alternative splicing of lncRNA-PXN-AS1. Nat Cell Biol. 19:820–832.
2017. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Zhou W, Chen X, Hu Q, Chen X, Chen Y and
Huang L: Galectin-3 activates TLR4/NF-κB signaling to promote lung
adenocarcinoma cell proliferation through activating lncRNA-NEAT1
expression. BMC Cancer. 18:5802018. View Article : Google Scholar : PubMed/NCBI
|
9
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Xia Y, Yan Z, Wan Y, Wei S, Bi Y, Zhao J,
Liu J, Liao DJ and Huang H: Knockdown of long noncoding RNA GHET1
inhibits cellcycle progression and invasion of gastric cancer
cells. Mol Med Rep. 18:3375–3381. 2018.PubMed/NCBI
|
11
|
Wu HF, Ren LG, Xiao JQ, Zhang Y, Mao XW
and Zhou LF: Long non-coding RNA LINP1 promotes the malignant
progression of prostate cancer by regulating p53. Eur Rev Med
Pharmacol Sci. 22:4467–4476. 2018.PubMed/NCBI
|
12
|
Wang P, Wu T, Zhou H, Jin Q, He G, Yu H,
Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1
promotes laryngeal squamous cell cancer through regulating
miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zou SM, Li WH, Wang WM, Li WB, Shi SS,
Ying JM and Lyu N: The gene mutational discrepancies between
primary and paired metastatic colorectal carcinoma detected by
next-generation sequencing. J Cancer Res Clin Oncol. 144:2149–2159.
2018. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cheng K, Zhao Z, Wang G, Wang J and Zhu W:
lncRNA GAS5 inhibits colorectal cancer cell proliferation via the
miR1825p/FOXO3a axis. Oncol Rep. 41:2371–2380. 2018.
|
15
|
Huang Z, Lei W, Tan J and Hu HB: Long
noncoding RNA LINC00961 inhibits cell proliferation and induces
cell apoptosis in human non-small cell lung cancer. J Cell Biochem.
119:9072–9080. 2018. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gandhi L, Rodriguez-Abreu D, Gadgeel S,
Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ,
Powell SF, et al: Pembrolizumab plus chemotherapy in metastatic
non-small-cell lung cancer. N Engl J Med. 378:2078–2092. 2018.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Miller VA, Hirsh V, Cadranel J, Chen YM,
Park K, Kim SW, Zhou C, Su WC, Wang M, Sun Y, et al: Afatinib
versus placebo for patients with advanced, metastatic
non-small-cell lung cancer after failure of erlotinib, gefitinib,
or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase
2b/3 randomised trial. Lancet Oncol. 13:528–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lu Z, Li Y, Che Y, Huang J, Sun S, Mao S,
Lei Y, Li N, Sun N and He J: The The TGFβ-induced lncRNA TBILA
promotes non-small cell lung cancer progression in vitro and in
vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
Cancer Lett. 432:156–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wei TY, Hsia JY, Chiu SC, Su LJ, Juan CC,
Lee YC, Chen JM, Chou HY, Huang JY, Huang HM and Yu CT: Methylosome
protein 50 promotes androgen- and estrogen-independent
tumorigenesis. Cell Signal. 26:2940–2950. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Sanchez-Palencia A, Gomez-Morales M,
Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R and Fárez-Vidal ME:
Gene expression profiling reveals novel biomarkers in nonsmall cell
lung cancer. Int J Cancer. 129:355–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hou J, Aerts J, den Hamer B, van Ijcken W,
den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens
JA, Hoogsteden HC, et al: Gene expression-based classification of
non-small cell lung carcinomas and survival prediction. PLoS One.
5:e103122010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wu J, Weng Y, He F, Liang D and Cai L:
lncRNA MALAT-1 competitively regulates miR-124 to promote EMT and
development of non-small-cell lung cancer. Anticancer Drugs.
29:628–636. 2018. View Article : Google Scholar : PubMed/NCBI
|
26
|
Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L
and Yin R: CCAT2 is a lung adenocarcinoma-specific long non-coding
RNA and promotes invasion of non-small cell lung cancer. Tumour
Biol. 35:5375–5380. 2014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Yang L, Xie N, Huang J, Huang H, Xu S,
Wang Z and Cai J: SIK1-LNC represses the proliferative, migrative,
and invasive abilities of lung cancer cells. Onco Targets Ther.
11:4197–4206. 2018. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhao JM, Cheng W, He XG, Liu YL, Wang FF
and Gao YF: Long non-coding RNA PICART1 suppresses proliferation
and promotes apoptosis in lung cancer cells by inhibiting
JAK2/STAT3 signaling. Neoplasma. 65:779–789. 2018. View Article : Google Scholar : PubMed/NCBI
|
29
|
Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and
De W: The long non-coding RNA HOTAIR indicates a poor prognosis and
promotes metastasis in non-small cell lung cancer. BMC Cancer.
13:4642013. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhang Q, Li X, Li X, Li X and Chen Z:
lncRNA H19 promotes epithelial-mesenchymal transition (EMT) by
targeting miR-484 in human lung cancer cells. J Cell Biochem.
119:4447–4457. 2018. View Article : Google Scholar : PubMed/NCBI
|
31
|
Zhang Z, Liu T, Wang K, Qu X, Pang Z, Liu
S, Liu Q and Du J: Down-regulation of long non-coding RNA MEG3
indicates an unfavorable prognosis in non-small cell lung cancer:
Evidence from the GEO database. Gene. 630:49–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
32
|
Lin PC, Huang HD, Chang CC, Chang YS, Yen
JC, Lee CC, Chang WH, Liu TC and Chang JG: Long noncoding RNA TUG1
is downregulated in non-small cell lung cancer and can regulate
CELF1 on binding to PRC2. BMC Cancer. 16:5832016. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zhang Y, Zhang P, Wan X, Su X, Kong Z,
Zhai Q, Xiang X, Li L and Li Y: Downregulation of long non-coding
RNA HCG11 predicts a poor prognosis in prostate cancer. Biomed
Pharmacother. 83:936–941. 2016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Yao XM, Tang JH, Zhu H and Jing Y: High
expression of lncRNA CASC15 is a risk factor for gastric cancer
prognosis and promote the proliferation of gastric cancer. Eur Rev
Med Pharmacol Sci. 21:5661–5667. 2017.PubMed/NCBI
|
35
|
Chen CQ, Chen CS, Chen JJ, Zhou LP, Xu HL,
Jin WW, Wu JB and Gao SM: Histone deacetylases inhibitor
trichostatin A increases the expression of Dleu2/miR-15a/16-1 via
HDAC3 in non-small cell lung cancer. Mol Cell Biochem. 383:137–148.
2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Shi H, Shi J, Zhang Y, Guan C, Zhu J, Wang
F, Xu M, Ju Q, Fang S and Jiang M: Long non-coding RNA DANCR
promotes cell proliferation, migration, invasion and resistance to
apoptosis in esophageal cancer. J Thorac Dis. 10:2573–2582. 2018.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Niu Y, Ma F, Huang W, Fang S, Li M, Wei T
and Guo L: Long non-coding RNA TUG1 is involved in cell growth and
chemoresistance of small cell lung cancer by regulating LIMK2b via
EZH2. Mol Cancer. 16:52017. View Article : Google Scholar : PubMed/NCBI
|
38
|
Chen W, Zhang X, Li J, Huang S, Xiang S,
Hu X and Liu C: Comprehensive analysis of coding-lncRNA gene
co-expression network uncovers conserved functional lncRNAs in
zebrafish. BMC Genomics. 19 (Suppl 2):S1122018. View Article : Google Scholar
|
39
|
Fang L, Wang H and Li P: Systematic
analysis reveals a lncRNA-mRNA co-expression network associated
with platinum resistance in high-grade serous ovarian cancer.
Invest New Drugs. 36:187–194. 2018. View Article : Google Scholar : PubMed/NCBI
|
40
|
Jiao J, Shi B, Wang T, Fang Y, Cao T, Zhou
Y, Wang X and Li D: Characterization of long non-coding RNA and
messenger RNA profiles in follicular fluid from mature and immature
ovarian follicles of healthy women and women with polycystic ovary
syndrome. Hum Reprod. 33:1735–1748. 2018. View Article : Google Scholar : PubMed/NCBI
|